”Improving Candidate Selection: Translating Molecules into Medicines.”

Bromodomain. A chromatin "reader" that is a target of PPI drug development. Source: WillowW at the English language Wikipedia.   Allan B. Haberman, Ph.D. was one of about 25 experts from pharmaceutical, biotechnology, and consulting firms who attended Aptuit’s  one-day think-tank event, ”Improving Candidate Selection: Translating Molecules into Medicines”. This was the third [...]

The post ”Improving Candidate Selection: Translating Molecules into Medicines.” appeared first on Haberman Associates.